Clarification10 April 2026 at 04:08 am
Zenotech Laboratories Addresses Share Price Volatility, Confirms SEBI Compliance and No Undisclosed Material Information
AI Summary
Zenotech Laboratories Ltd responded to an inquiry from the stock exchange regarding a significant recent movement in its share price. The company confirmed its adherence to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30. Zenotech explicitly stated that it has not withheld any material information or impending announcements that, in its opinion, could be responsible for the recent price behavior of its shares. This clarification was issued on April 10, 2026, in response to an email from the exchange, reiterating the company's commitment to transparency and regulatory compliance.
Key Highlights
- Zenotech Laboratories received an inquiry from the stock exchange concerning a significant recent movement in its share price.
- The company affirmed its full compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015, regarding disclosure obligations.
- Zenotech explicitly stated that it has not withheld any material information or events that could explain the recent price volatility in its stock.
- The clarification aims to reassure investors and the market that no undisclosed corporate developments are driving the stock's price action.